Literature review no device return.Initial medwatch submitted to the fda on 27/may/2022.A review of the device labeling notes the following: the current overstitch¿ endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "other (migrated of suture)" as follows: warnings: do not use a device where the integrity of the sterile packaging has been compromised or if the device appears damaged.Only physicians possessing sufficient skill and experience in similar or the same techniques should perform endoscopic procedures.Contact of electrosurgical components with other components may result in injury to the patient and/or operator as well as damage to the device and/or endoscope.Verify compatibility of endoscopic instruments and accessories and ensure performance is not compromised.Note: refurbished scopes may no longer confirm to original specifications.Ensure that there is sufficient space for the needle to open.Ensure that the handle grip of the endoscopic suturing system is closed and locked during intubation and extubation.Users should be familiar with surgical procedures and techniques involving absorbable sutures before employing synthetic absorbable sutures for wound closure, as the risk of wound dehiscence may vary with the site of application and the suture material used.Additional information: the device will not be returned for analysis, and since it is not possible to gather more information from the reporter, no additional information will be received.The investigator determined a device history record (dhr) review is not possible for this complaint, as attempts at gathering the device serial/lot number were unsuccessful.
|